daunorubicin

medtigo

daunorubicin

Brand Name :

Myocet, Adriamycin, Caelyx, Rubex

Synonyms :

Class :

Antineoplastic agents: antibiotics & cytotoxics

Action and Spectrum

Dosing & Uses

Drug Interaction

Adverse Reaction

Frequency defined:

>10%:

ECG abnormality

Ventricular premature contractions

Alopecia

Nausea

Vomiting

Weight loss

Mucositis

Anorexia

Myelosuppression

Pulmonary fibrosis

1% to 10%

Discoloration of sweat

Hyperuricemia

Diarrhea

Gastrointestinal ulcer

Discoloration of saliva

<1%

Anaphylactoid

Cardiac failure

Cardiac arrhythmia

Hepatitis

Increased serum bilirubin

Infertility

Nail banding

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy: Daunorubicin falls under the pregnancy category D. daunorubicin can cross the placenta and can cause fetal harm.

Lactation: excretion of daunorubicin in breast milk is unknown

Pregnancy category:

Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or the later trimester.
Category B: There is no evidence of risk to the fetus found in animal reproduction studies and there are not enough studies on pregnant women.
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women.
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh risks over benefits. These category drugs should be prohibited for pregnant women.
Category N: There is no data available for the drug under this category.

Pharmacology

Adminstartion

Patient Information Leaflet

Daunorubicin is an anti-cancer agent used to treat leukemia.

Tell your physician if you have any side effects like chills, fever, tiredness, easy bruising, or unusual bleeding.

Do not take daunorubicin if you are allergic to it, and inform your doctor if you have any previous allergies.

Daunorubicin is harmful to the ingrowing fetus.

Inform the doctor about your pregnancy or plan of conception.

The pregnancy should be planned three months after the last dose of daunorubicin.

Both men and women should opt for effective birth control methods during the treatment.

The skin should not get exposed to this drug. If it encounters skin, rinse and wash off with soap.

If you miss a dose, ask your physician to reschedule it.

Overdose shall not occur as the medical professional administers it.

Keep the medication away from children, and do not share your medicines with others.

daunorubicin

No data available for drug.

DRUG INTERACTION

daunorubicin

&

daunorubicin +

Contraindicated

Serious Use Alternative

Monitor Closely

Minor

daunorubicin

No data available for drug.

DRUG INTERACTION

daunorubicin

&

daunorubicin +

Contraindicated

Serious Use Alternative

Monitor Closely

Minor

medtigo

daunorubicin

Brand Name :

Synonyms :

Class :

Action and Spectrum

Dosing & Uses

Drug Interaction

Adverse Reaction

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pharmacology

Adminstartion

Patient Information Leaflet